Noble Life Sciences Animal Facility Awarded Full AAALAC Accreditation
News Nov 01, 2013
Noble Life Sciences has announced that its animal facility was awarded full accreditation by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC International).
AAALAC assessment and accreditation programs are designed to recognize organizations that demonstrate excellence in animal care and use.
Organizations volunteer to participate in AAALAC's program in addition to complying with local, state and federal laws that regulate use of animals in research.
Accreditation was awarded following submission of a detailed program description and an in-depth review of the program and facility during an on-site visit by AAALAC representatives.
In addition, Noble is currently licensed by the United States Department Of Agriculture (USDA) and meets the assurance requirements of the National Institutes of Health’s Office of Laboratory Animal Welfare (OLAW).
Alain Cappeluti, President of Noble Life Sciences, commented: “We are pleased to receive unanimous approval from AAALAC International for full accreditation with no additional recommendations for improvement. Accreditation recognizes our commitment to exceed international standards with the highest level of animal care and research practices. It also demonstrates our dedication to providing our clients with superior resources and services to advance their preclinical research programs.”
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Cancer Cells Force Normal Cells to Act Like Viruses, Helping Tumors SpreadNews
Researchers reveal how cancer cells force normal cells to act like viruses – allowing tumors to grow, resist treatment, and spread.READ MORE
Edith Heard Unanimously Selected as Next Director General of EMBLNews
At its 53rd meeting yesterday, EMBL Council selected Edith Heard as the organization’s fifth Director General. Heard’s mandate is scheduled to begin 1 January 2019.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018